Weekly Reports | Jun 25 2021
Our top ten news from 17 June 2021 to 24 June 2021 (ranked according to popularity).
1 – CSL: Buy The Dip
Tuesday 22 June 2021
Michael Gable of Fairmont Equities suggests CSL is set for a short term share price dip, providing an attractive entry point
2 – Material Matters: Coal, Base Metals & Iron Ore
Monday 21 June 2021
A glance through the latest expert views and predictions about commodities: drilling; thermal coal; base metals; iron ore; and potash
3 – Long Lost Small Caps Seeing The Light
Thursday 17 June 2021
The New Criterion's Tim Boreham examines three long established ASX small caps that may be set to not be so small
4 – Uranium Week: Uranium Equities Fall On Reactor Fears
Tuesday 22 June 2021
As the uranium spot price rises 14% over the last eight weeks, uranium shares tumble on concerns over a Chinese nuclear reactor
5 – Beyond Bitcoin: Ethereum and DeFi
Monday 21 June 2021
In Part III of FNArena's exploration of crypto currency, we examine the rise of Ethereum, and the implications of Ethereum's far more extensive application capacity
6 – What To Sell For Year-End Tax Losses
Wednesday 23 June 2021
The New Criterion's Tim Boreham identifies a list of stocks that could be sold for tax losses without subsequently missing a boat
7 – The Wrap: Trade Deal, China, Demergers, Consumer Spending
Friday 18 June 2021
Weekly Broker Wrap: Trade deal with the UK, China consumption softens, Woollies calls time on drinks, consumer spend shift
8 – Contractors: The Best & Worst Of Times
Thursday 17 June 2021
Just when commodity prices are enjoying boom times, along come labour shortages to frustrate the contractor services sector
9 – Iron Ore: Remain Bullish
Thursday 17 June 2021
The Chartist notes the prices of iron ore and its miners have taken a breather, but the technicals suggest resumption of the uptrend
10 – Fund Managers' Mid-Year Review
Wednesday 23 June 2021
As sharemarkets continue to rebound, fund managers target sectors and stocks appropriate to the next stage of the economic cycle and a new post-covid normal
